Pages that link to "Q34725029"

The following pages link to Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner. (Q34725029):

Displaying 27 items.

• Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing (Q26801060) (← links)
• A review of the past, present, and future directions of neoplasia (Q28389391) (← links)
• Neoplasia: Where We Have Been and Where We Are Going (Q28395095) (← links)
• Transient reduction of placental angiogenesis in PAI-1-deficient mice (Q28510418) (← links)
• Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. (Q33295022) (← links)
• Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer (Q33467391) (← links)
• Does plasminogen activator inhibitor-1 drive lymphangiogenesis? (Q33543002) (← links)
• PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma (Q33693105) (← links)
• SFRP1 reduction results in an increased sensitivity to TGF-β signaling (Q33814892) (← links)
• Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor. (Q34887726) (← links)
• Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells (Q36311530) (← links)
• Bone marrow mesenchymal stem cells are abnormal in multiple myeloma (Q36593549) (← links)
• Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover. (Q36640228) (← links)
• Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study (Q37317112) (← links)
• Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression (Q37318149) (← links)
• Impact of alkylphospholipids on the gene expression profile of HaCaT cells (Q38501802) (← links)
• PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes (Q39709591) (← links)
• SERPINE1 expression discriminates site-specific metastasis in human melanoma (Q42049845) (← links)
• Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway (Q42136467) (← links)
• TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. (Q42399810) (← links)
• TGF-beta1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy (Q43146931) (← links)
• Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors (Q46407013) (← links)
• Neoplasia: An Anniversary of Progress (Q46932476) (← links)
• MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib (Q50455931) (← links)
• The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects. (Q51823101) (← links)
• Effects of a High-Fat or High-Sucrose Diet on Ultraviolet B Irradiation-Induced Carcinogenesis and Tumor Growth in Melanin-Possessing Hairless Mice. (Q52876816) (← links)
• Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model (Q89554275) (← links)